@article{d10d71fb3473435db9b2d8e8d6e3b78e,
title = "DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network",
keywords = "Anticoagulants, Body mass index, Factor Xa inhibitors, Thinness, Venous thromboembolism, Warfarin",
author = "Martin, {Karlyn A.} and Nicola Lancki and Kreuziger, {Lisa Baumann} and Celina Li and Eyster, {M. Elaine} and Kristen Sanfilippo and Woller, {Scott C.} and Rosovsky, {Rachel P.}",
note = "Funding Information: This study was funded by Janssen Scientific Affairs . Janssen reviewed the study protocol and manuscript but was not involved in the data analysis or manuscript writing. KM is supported by K23HL157758 . Research reported in this publication was supported, in part, by the National Institutes of Health's National Center for Advancing Translational Sciences , Grant Number UL1TR001422 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ",
year = "2023",
month = sep,
doi = "10.1016/j.thromres.2023.07.004",
language = "English",
volume = "229",
pages = "146--148",
journal = "Thrombosis Research",
issn = "0049-3848",
}